Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L M Jansen

Showing results (141-150 of 150) with videos related to

Pageof 15
Sort By:
You have reached the last page of results.This site can display upto 150 results.
Scandinavian Journal of Gastroenterology|September 23, 2006
Absence of association between the multidrug resistance (MDR1) gene and inflammatory bowel diseaseLiekele E Oostenbrug, Gerard Dijkstra, Ilja M Nolte, et al.
Obesity (Silver Spring, Md.)|April 18, 2013
Accuracy of prediction scores and novel biomarkers for predicting nonalcoholic fatty liver disease in obese childrenBart G P Koot, Olga H van der Baan-Slootweg, Anneloes E Bohte, et al.
European Radiology|October 26, 2013
Non-invasive evaluation of liver fibrosis: a comparison of ultrasound-based transient elastography and MR elastography in patients with viral hepatitis B and CAnneloes E Bohte, Annikki de Niet, Louis Jansen, et al.
Antiviral Therapy|May 4, 2013
Baseline hepatitis B surface antigen (HBsAg) as predictor of sustained HBsAg loss in chronic hepatitis B patients treated with pegylated interferon-α2a and adefovirR Bart Takkenberg, Louis Jansen, Annikki de Niet, et al.
Journal of Inherited Metabolic Disease|July 30, 2016
Cholic acid therapy in Zellweger spectrum disordersKevin Berendse, Femke C C Klouwer, Bart G P Koot, et al.
Antiviral Therapy|August 17, 2010
Safety and antiviral activity of JTK-652: a novel HCV infection inhibitorJoep de Bruijne, Jilling F Bergmann, Christine J Weegink, et al.
Journal of Inherited Metabolic Disease|February 23, 2019
The cholic acid extension study in Zellweger spectrum disorders: Results and implications for therapyFemke C C Klouwer, Bart G P Koot, Kevin Berendse, et al.
The Netherlands Journal of Medicine|October 17, 2014
Hepatocellular carcinoma: Dutch guideline for surveillance, diagnosis and therapyF A L M Eskens, K J van Erpecum, K P de Jong, et al.
Hepatology (Baltimore, Md.)|August 14, 2018
Bile Microinfarcts in Cholestasis Are Initiated by Rupture of the Apical Hepatocyte Membrane and Cause Shunting of Bile to Sinusoidal BloodAhmed Ghallab, Ute Hofmann, Selahaddin Sezgin, et al.
Journal of Hepatology|February 6, 2017
Novel serum and bile protein markers predict primary sclerosing cholangitis disease severity and prognosisMette Vesterhus, Anders Holm, Johannes Roksund Hov, et al.
Pageof 15

Showing results (141-150 of 150) with videos related to

Sort By:
Pageof 15
You have reached the last page of results.This site can display upto 150 results.
Scandinavian Journal of Gastroenterology|September 23, 2006
Absence of association between the multidrug resistance (MDR1) gene and inflammatory bowel diseaseLiekele E Oostenbrug, Gerard Dijkstra, Ilja M Nolte, et al.
Obesity (Silver Spring, Md.)|April 18, 2013
Accuracy of prediction scores and novel biomarkers for predicting nonalcoholic fatty liver disease in obese childrenBart G P Koot, Olga H van der Baan-Slootweg, Anneloes E Bohte, et al.
European Radiology|October 26, 2013
Non-invasive evaluation of liver fibrosis: a comparison of ultrasound-based transient elastography and MR elastography in patients with viral hepatitis B and CAnneloes E Bohte, Annikki de Niet, Louis Jansen, et al.
Antiviral Therapy|May 4, 2013
Baseline hepatitis B surface antigen (HBsAg) as predictor of sustained HBsAg loss in chronic hepatitis B patients treated with pegylated interferon-α2a and adefovirR Bart Takkenberg, Louis Jansen, Annikki de Niet, et al.
Journal of Inherited Metabolic Disease|July 30, 2016
Cholic acid therapy in Zellweger spectrum disordersKevin Berendse, Femke C C Klouwer, Bart G P Koot, et al.
Antiviral Therapy|August 17, 2010
Safety and antiviral activity of JTK-652: a novel HCV infection inhibitorJoep de Bruijne, Jilling F Bergmann, Christine J Weegink, et al.
Journal of Inherited Metabolic Disease|February 23, 2019
The cholic acid extension study in Zellweger spectrum disorders: Results and implications for therapyFemke C C Klouwer, Bart G P Koot, Kevin Berendse, et al.
The Netherlands Journal of Medicine|October 17, 2014
Hepatocellular carcinoma: Dutch guideline for surveillance, diagnosis and therapyF A L M Eskens, K J van Erpecum, K P de Jong, et al.
Hepatology (Baltimore, Md.)|August 14, 2018
Bile Microinfarcts in Cholestasis Are Initiated by Rupture of the Apical Hepatocyte Membrane and Cause Shunting of Bile to Sinusoidal BloodAhmed Ghallab, Ute Hofmann, Selahaddin Sezgin, et al.
Journal of Hepatology|February 6, 2017
Novel serum and bile protein markers predict primary sclerosing cholangitis disease severity and prognosisMette Vesterhus, Anders Holm, Johannes Roksund Hov, et al.
Pageof 15